Childhood Obesity Tied to Pediatric Immune-Mediated Skin Diseases
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 27, 2024 -- Early childhood obesity may increase the risk for pediatric immune-mediated skin diseases, according to a study published online Aug. 21 in the Journal of Investigative Dermatology.
Seong Rae Kim, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined associations between body mass index or body mass index changes and the development of three main immune-mediated skin diseases: alopecia areata, atopic dermatitis (AD), and psoriasis in a longitudinal cohort of roughly 2.16 million Korean children (2009 to 2020).
The researchers found that children with obesity had a significantly higher risk for pediatric immune-mediated skin diseases than those with normal weight. A higher risk for AD was seen with an increase in body mass index, while a decrease in body mass index correlated with a reduced risk for AD. Transitioning from normal weight to overweight was associated with higher AD risk compared with maintaining a normal weight (adjusted hazard ratio, 1.15). However, those with a decrease in body mass index (overweight to normal weight) had lower AD risk (adjusted hazard ratio, 0.87) versus children who maintained overweight.
"Implementing purposeful interventions, including nutritional strategies, to decrease body weight may aid in reducing the risk of developing immune-mediated skin diseases in children," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide
FRIDAY, Sept. 13, 2024 -- For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent, dosage...
At Least One in Five People Has Obesity in Each U.S. State
THURSDAY, Sept. 12, 2024 -- Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity, according...
Liraglutide Efficacious, Safe for Children Aged 6 to
THURSDAY, Sept. 12, 2024 -- Liraglutide plus lifestyle intervention is efficacious for children aged 6 to <12 years with obesity, according to a study published online Sept. 10...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.